Wikidata

(Q53921000)

English

Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancer.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12912943
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12912943%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53921000&oldid=2143796616"